Propofol versus alfentanil to prevent movement responses during uterine curettage

Authors: Seitsonen; Cohen-Laroque1; vanGils2; Korttila3; Neuvonen4; Yli-Hankala5

Source: Acta Anaesthesiologica Scandinavica, Volume 51, Number 6, July 2007 , pp. 751-758(8)

Publisher: Blackwell Publishing

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Abstract:

Background: 

Propofol anaesthesia is frequently associated with movement responses in non-paralysed patients. Opioids decrease the probability of movement during noxious stimulation. Heart rate variability and frontal electromyography (EMG), which are related to subcortical functions, may be more closely related than surface electroencephalography (EEG) to movement responses to noxious stimulation. Methods: 

Eighty-two patients scheduled for uterine dilatation and curettage were randomized to receive at the first intra-operative movement either a supplemental alfentanil bolus, 0.5 mg intravenously, or a supplemental propofol bolus, 0.7 mg/kg intravenously. The incidences of recurring movement during the procedure were compared between the two groups. The associations of a measure of heart rate variability (Anemon index), heart rate, EMG and two EEG variables with movement responses were evaluated. Results: 

The incidences of recurring movement were 73% and 38% in the alfentanil and propofol groups, respectively [difference, 35%; 95% confidence interval, 9-56%; P= 0.014 between the groups). The Anemon index, heart rate, EMG and surface EEG variables displayed mainly reactive associations with movement responses. Conclusion: 

During uterine curettage under propofol-alfentanil-nitrous oxide anaesthesia, a propofol bolus of 0.7 mg/kg was more effective in preventing the recurrence of movement responses than an alfentanil bolus of 0.5 mg. Several physiological variables may be used to track significant arousal reactions, but not to predict them.

Keywords: alfentanil; anaesthesia; electroencephalography; electromyography; heart rate; intra-operative; monitoring; movement; propofol

Document Type: Research article

DOI: 10.1111/j.1399-6576.2007.01309.x

Affiliations: 1: Broad Bay, Dunedin, New Zealand 2: VTT Technical Research Centre of Finland, Tampere, Finland 3: Helsinki University Central Hospital, Department of Anaesthesia and Intensive Care, Helsinki, Finland 4: University of Helsinki and Helsinki University Central Hospital, Department of Clinical Pharmacology, Helsinki, Finland 5: Tampere University Hospital, Department of Anaesthesia, and University of Tampere, Medical School, Tampere, Finland

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$50.16 plus tax      Refund Policy

 

OR

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A